Consolidated statement of changes in stockholders' equity - EUR (€) € in Thousands |
Share capital |
Treasury Shares, at cost |
Additional paid-in capital |
Foreign currency translation |
Revaluation reserve |
Retained Earnings |
Total |
|---|---|---|---|---|---|---|---|
| Beginning balance at Dec. 31, 2022 | € 176,953 | € 1,440,010 | € (16,289) | € (21,113) | € (392,377) | € 1,187,184 | |
| Beginning balance (Shares) at Dec. 31, 2022 | 176,952,653 | 176,953,000 | |||||
| Exercised stock options | € 233 | € 233 | |||||
| Exercised stock options (shares) | 233,083 | ||||||
| Stock option plan | 9,630 | 9,630 | |||||
| Transaction costs | 14 | 14 | |||||
| Other comprehensive income | (1,760) | 8,519 | 6,759 | ||||
| Net income (loss) for the period | (83,913) | (83,913) | |||||
| Total comprehensive income (loss) | (1,760) | 8,519 | (83,913) | (77,153) | |||
| Ending balance at Dec. 31, 2023 | € 177,186 | 1,449,654 | (18,049) | (12,594) | (476,290) | € 1,119,908 | |
| Ending balance (Shares) at Dec. 31, 2023 | 177,185,736 | 177,186,000 | |||||
| Exercised stock options | € 368 | € 368 | |||||
| Exercised stock options (shares) | 367,720 | ||||||
| Stock option plan | 5,034 | 5,034 | |||||
| Other comprehensive income | 23,127 | 167 | 23,294 | ||||
| Net income (loss) for the period | (196,078) | (196,078) | |||||
| Total comprehensive income (loss) | 23,127 | 167 | (196,078) | (172,785) | |||
| Ending balance at Dec. 31, 2024 | € 177,553 | 1,454,688 | 5,078 | (12,427) | (672,370) | € 952,525 | |
| Ending balance (Shares) at Dec. 31, 2024 | 177,553,456 | 177,553,000 | |||||
| Exercised stock options | € 225 | € 225 | |||||
| Exercised stock options (shares) | 225,451 | 225,451 | |||||
| Stock option plan | 3,778 | € 3,778 | |||||
| Purchase of treasury shares | € (1,548) | (1,548) | |||||
| Other comprehensive income | (39,032) | 1,273 | (37,759) | ||||
| Net income (loss) for the period | (103,517) | (103,517) | |||||
| Total comprehensive income (loss) | (39,032) | 1,273 | (103,517) | (141,276) | |||
| Ending balance at Dec. 31, 2025 | € 177,779 | € (1,548) | € 1,458,466 | € (33,954) | € (11,154) | € (775,887) | € 813,704 |
| Ending balance (Shares) at Dec. 31, 2025 | 177,778,907 | 177,778,907 |
| X | ||||||||||
- Definition Number of share options (or share units) exercised during the current period. No definition available.
|
| X | ||||||||||
- Definition The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of residual interest in the assets of the entity after deducting all its liabilities. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The increase (decrease) in equity resulting from the exercise of options. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of shares issued by the entity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The decrease in equity resulting from the purchase of treasury shares. [Refer: Treasury shares] Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|